Morrisville, N.C. - November 26, 2007 - Centice Corporation, a pioneer in next generation sensor technology, today announced that the company expanded its patent portfolio with the recent patent award for “Rapid Pharmaceutical Verification and Identification System.”

This patent (US Patent No. 7,218,395) describes a fully automated pharmaceutical identification and verification system that operates through a prescription vial or bottle without requiring cap removal/replacement, while providing superior verification speeds with higher accuracy. “We are very pleased with the award of this patent. This patent is based upon the use of our previously patented Multimodal Multiplex Sensor platform technology.” said Prasant Potuluri, Ph.D., CTO of Centice.

“This patent award demonstrates the applicability of Centice’s core sensor technology to solve significant real-world problems. The PASS Rx™ pharmaceutical authentication sensor system, planned for 2008 availability, will improve the patient safety by enhancing the quality assurance process for dispensed medications.” said Ray W. Swanson, President and CEO.

About Centice
Centice, founded in 2004, is commercializing patented and patent-pending computational sensor technology originally developed at Duke University. The PASS Rx™ pharmaceutical authentication sensor system is the Company’s first product. The PASS Rx™ system has the potential to improve the verification process for dispensed medications, thereby increasing patient safety, and is anticipated for market availability in 2008. The company has received venture capital investments from The Aurora Funds, Inc., Novak Biddle Venture Partners, S-Group Direct Investments Ltd, and Innovation Ventures LP. More information on Centice can be found at http://www.centice.com.

Company Contact
John Davis

VP, Business Development

jdavis@centice.com

Phone: (919) 653-0424, x149